IMMUNOBIOLOGICAL AGENT FOR THERAPY OF ONCOLOGICAL DISEASES BASED ON mRNA VECTOR
2024-06-29
专利权人FEDERAL STATE BUDGETARY INST (FSBI-C)
申请日期2024-06-29
专利号RU2828631-C1
成果简介NOVELTY - Group of inventions relates to immunology and oncology. What is developed is an immunobiological agent based on mRNA, in which the mRNA contains a sequence selected from: SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 8, at 5'-end; an open reading frame encoding from 1 to 80 tumour gene signatures; sequence SEQ ID NO: 6 or SEQ ID NO: 7 at 3'-end. Also disclosed is a method for preparing the agent and use thereof. USE - Medicine. ADVANTAGE - Presented group of inventions extends the range of agents and methods for inducing immune response in patients with oncological diseases and can be used in therapy of patients with oncological diseases of various aetiologies. 5 cl, 4 dwg, 1 tbl, 8 ex
IPC 分类号A61K-039/00 ; A61P-035/00 ; C12Q-001/68
国家俄罗斯
专业领域生物科学
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/16046
专题中国科学院新疆生态与地理研究所
作者单位
FEDERAL STATE BUDGETARY INST (FSBI-C)
推荐引用方式
GB/T 7714
GINTSBURG A L,KAPRIN A D,LOGUNOV D YU,et al. IMMUNOBIOLOGICAL AGENT FOR THERAPY OF ONCOLOGICAL DISEASES BASED ON mRNA VECTOR. RU2828631-C1[P]. 2024.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。